Introduction
GPs regularly assess patients presenting with symptoms suggestive of lower respiratory tract infection (LRTI), which can include acute bronchitis and pneumonia. 1 The dilemma of differentiating between these diagnoses, using history and physical examination, is challenging. 2 Recent studies have shown that relying on clinical findings alone do not predict persistence of cough duration or functional impairment in terms of the subsequent clinical course of illness in individual patients. 3 C-reactive protein (CRP) is an acute-phase protein, which is synthesized by the liver in response to infection or tissue inflammation. A range of cytokines, including interleukin-6, interleukin-1b and tumour necrosis factor, stimulate its production. 4 CRP was first identified in 1930 from the observation of patients with pneumonia. Its name was derived from the fact that it reacted with the pneumococcal C-polysaccharide in patients' plasma during the acute phase of pneumococcal pneumonia. Subsequently, it has been recognized as a marker of inflammation, a so-called 'acute-phase protein'. An acute-phase protein has been described as a protein whose plasma concentration increases or decreases by at least 25% during an inflammatory process. 5 Serum concentration of CRP is normally <3 mg/l; but following severe infection or inflammation, it can rise above 500 mg/l. CRP near-patient tests are now widely available and can accurately detect CRP levels >8 mg/l. 6, 7 A normal CRP in a patient with symptoms of respiratory infection most likely indicates a self-limiting infection that does not require referral to hospital or antibiotic treatment. However, it is important that physicians are aware that a normal value may be observed early in an illness, before the 'acute-phase' response has been mounted. 8 The ability to differentiate pneumonia from other LRTIs, such as acute bronchitis, is important for several reasons. First, missing a diagnosis of pneumonia may have fatal consequences for a patient. 9, 10 Second, inappropriate prescribing of antibiotics to patients with acute bronchitis increases the risk of side effects-more commonly rash and gastrointestinal upset and less commonly anaphylactic reactions. This practice can thereby 'medicalize' a self-limiting illness and contribute to the public health problem of antibioticresistant organisms in the community. 11, 12 Uptake of CRP testing in primary care has been increasing throughout Europe, for instance a CRP assay is now widely used in the Scandinavian countries and in Switzerland. 13 In Norway, a survey carried out in 2002 revealed that 41% of all patients consulting with an airway infection had a CRP test. The purpose of this systematic review is to evaluate CRP as a nearpatient test in the diagnosis of community-acquired pneumonia (CAP) in the community.
Methods
Search strategy An electronic search was performed following the guidelines of Haynes et al.
14 PubMed was searched from January 1966 to September 2008 and EMBASE from January 1980 to July 2008. Combinations of the phrases 'C-reactive protein', 'pneumonia', 'community-acquired pneumonia', 'General Practice', 'Family Practice', 'Emergency Department' and 'Primary care' were used. This search was supplemented by handchecking references of filtered papers, searching Google Scholar and searching the Cochrane database. The MEDION database at the University of Maastricht, which contains over 300 reviews published on diagnostic and screening studies, was also searched. 15 Because of funding constraints allied to evidence concerning the more limited contribution of non-English language papers to systematic reviews, we limited our search to English language papers only. 16 
Study selection
The inclusion and exclusion criteria were as follows:
Population-participants in each study were to be recruited from a community, primary care setting or ambulatory setting, for example emergency departments, and have symptoms suggestive of acute respiratory infection suggestive of LRTI. Study design and reference standard-the study should assess the diagnostic accuracy by means of a cross-sectional study and use chest X-ray as the reference (gold) standard for determining presence of CAP. Index test-the study must assess the use of CRP in diagnosing CAP. Outcome measures-studies must present data that will allow the construction of 2 Â 2 tables for the assessment of diagnostic accuracy of CRP in diagnosing CAP.
Assessment of study quality In order to assess the quality of each included study, a nine-point modified Quality Assessment of Studies of Diagnostic Accuracy (QUADAS) quality analysis score was applied. 17 Data extraction and analysis Data were extracted from individual studies and 2 Â 2 tables constructed in relation to each diagnostic accuracy study of CRP. We pooled individual diagnostic accuracy studies using the statistical package MetaDiSc 18 and calculated pooled positive and negative likelihood ratios (LRs) using a random-effects model. LRs indicate by how much a given diagnostic test result will raise or lower the pretest probability of a target disorder, in this instance the presence of CAP, to a post-test probability. LRs of >1 increase the probability of CAP and <1 decrease the probability of CAP. In general terms, LRs >5 or <0.2 generate 'moderate' shifts, while LRs of >2 or <0.5 generate 'small' shifts in pretest to post-test probability. 19 We visually examined the presence or absence of heterogeneity and quantified heterogeneity by means of the chi-square statistic called the 'inconsistency index' or 'I 2 index'. This index describes the percentage of total variation across studies due to heterogeneity rather than chance. 20 Higgins et al. suggest 'assigning the adjectives low, moderate and high (heterogeneity) to I 2 of 25%, 50% and 75%', respectively. 20 In our analysis, the following approach was adopted. When I 2 <50%, data were taken to be sufficiently homogeneous to allow pooling, and summary estimates [and their 95% confidence interval (CI)] of diagnostic test accuracy in the form of positive or negative LRs were calculated. An I 2 >50% was taken to indicate significant between-study heterogeneity. In these instances, the ranges of positive and negative LRs from each of the included studies are presented.
We analysed and pooled results utilizing three different cut-points of CRP (<20, <50, >100 mg/l) in order to assess the diagnostic value of CRP in 'ruling in' or 'ruling out' CAP. We applied these different cutpoints across the spectrum of prior probability for CAP in order to assess the diagnostic value of a 'positive' or 'negative' (depending of the cut-point) CRP result.
Results
Our search yielded eight papers that satisfied our inclusion criteria for the study. [21] [22] [23] [24] [25] [26] [27] Figure 1 illustrates the flow of studies through the review process.
Characteristics and quality of included studies
The webtable 1 (see Appendix) outlines the important characteristics of each study. Among the 2194 patients included in the eight studies, there was substantial variation in the prevalence of CAP (median 16%, range 5%-89%). The use of CRP in diagnosing CAP was assessed using cut-offs ranging from 11 to 200 mg/l. Overall quality of included studies was moderate (webtable 1) with clear selection criteria, all recruited patients receiving index and reference standard tests incorporating blind outcome assessment in six studies. However, the possibility of spectrum bias was high in some of the included studies with a wide range of prevalence of CAP being reported and variation in the inclusion criteria.
Definition of the reference standard test for CAP All studies used chest X-ray as their reference standard but the criteria for defining CAP varied between studies. Four studies were non-specific, using terms like 'new infiltrate' or 'radiologically diagnosed CAP'. Two of these four studies explicitly stated that radiologists read the radiographs. Two other studies were more specific, specifying a lateral and posterioranterior chest X-ray and interpretation by two or more radiologists; one of whom was a senior member of staff. The remaining two studies combined an infiltrate on X-ray with symptoms suggestive of a LRTI.
Diagnostic value of CRP
The pooled LRs for different CRP cut-points are shown in Figure 2 . Only at the cut-point of a CRP of <20 mg/l were the individual LRs reported from six studies sufficiently homogeneous to allow pooling, with the pooled positive LR+ being 2.1 (95% CI 1.8-2.4) and the pooled negative LR-being 0.33 (95% CI 0.25-0.43). At the two other CRP cut-points (<50, >100 mg/ l), the results were heterogeneous, so the pooled results should be interpreted with caution (Fig. 2) .
Discussion
Clinical interpretation of results Our findings suggest that CRP testing when the cutpoint is set at <20 mg/l has limited use in ruling out CAP in patients presenting with symptoms of LRTI in community or ambulatory settings. The critical element to this interpretation relates to the prior probability of CAP, which we found to be highly variable in the included studies in this review, with the prevalence FIGURE 1 Flow of studies through review process Family Practice-an international journal of CAP varying from 5% to 89%. The nomogram (Fig. 3) shows the combinations of prior and corresponding posterior probabilities calculated using the lower and upper bounds of the 95% CI around the pooled negative LR estimate when the CRP cut-point is <20 mg/l. The largest absolute difference between prior and posterior probabilities occurs when the prior for CAP is in the intermediate range (40%-80%). However, in community settings, the prevalence of CAP in a recent community-based cohort study appears to be around 6%, 1 so in situations of low prior prevalence such as this a negative test result will not substantially reduce the probability of CAP (Fig. 3) . In situations where the prior probability of CAP is higher, for example in hospital accident and emergency settings, then a negative CRP test result when the cut-point is set at <20 mg/l may provide important diagnostic information in terms of ruling out CAP. These findings highlight the different diagnostic value of CRP, depending on the setting of care.
In the same way, we estimated the diagnostic value of a positive test result when the CRP cut-point is at >100 mg/l based on the range of positive LRs reported in the included studies (Fig. 2) . In this instance, the diagnostic range of a positive test result is wide, with the highest reported LR+ (51.8) having a substantial impact on ruling in CAP, 21 while the lowest reported LR+ (2.3), 28 having a negligible impact and not convincingly raising the posterior probability of CAP (Fig. 4) . Further research is needed to assess and refine the diagnostic utility of CRP at a cut-point of >100 mg/l, in terms of ruling in a diagnosis of CAP, irrespective of the setting of care.
Context of previous studies
Our pooled estimates are consistent with a previous review which concluded that CRP was neither FIGURE 2 Positive and negative LRs for CRP cut-points (1) cut-point < 20 mg/l (2) cut-point < 50 mg/l (3) cut-point > 100 mg/l FIGURE 3 The probability nomogram for the post-test probability of CAP: higher and lower 95% CI estimates of pooled negative LR for a CRP cut-point of <20 mg/l sufficiently sensitive to 'rule out' nor sufficiently specific to 'rule in' an infiltrate on chest X-ray. 29 However, we qualify our interpretation of the diagnostic value of CRP in two ways. First, in relation to the prior prevalence of CAP which in turn relates to the setting of care each individual patient presents to. A negative test result at cut-point <20 mg/l is not likely to be informative in community/ambulatory setting but could be useful in accident and emergency settings where the initial prior probability of CAP is in the intermediate range. Second, a negative or positive CRP result may produce additional diagnostic information if the patient presenting has additional symptoms or signs that revises the initial prior probability of CAP into the intermediate range. For example, Hopstaken et al. 26 show that in situations where the prior of CAP was 13%, patients presenting with a dry cough, diarrhoea or recorded temperature >38°C should have the probability of CAP revised upwards, as these clinical features are independently associated with CAP. A positive or negative CRP result (cut-point < 20 mg/l) in these situations is likely to be more diagnostically informative.
Shortcomings of the review
Our analysis clearly contains considerable population heterogeneity. Some studies take place in a general practice setting and others in the accident and emergency departments of different-sized hospitals. The studies are geographically diverse and the prior probabilities range from 5% to 89%. It is essential that GPs recognize and understand the implications of using a diagnostic test derived in a clinical setting different from their own. Similarly, it is critical that any interpretation of a near-patient test such as CRP is made having taken into account the clinical features in an individual patient and then revising the probability of CAP before proceeding to CRP testing. If a patient has few or no features of CAP, then further diagnostic testing in the community is likely to be uninformative.
Future studies
Further studies are required that assess the diagnostic value of CRP at different cut-points, so that the precision and accuracy of CRP can be established. In addition, the predictive value of clinical signs, particularly focal lung signs, is less substantial than GPs assume while at the same time being strongly associated with the probability of antibiotic prescribing. 3, 30 Future studies should examine the incremental value of symptoms and signs alongside CRP testing. Ideally, clinical prediction rules for the presence/absence of CAP should be developed and validated, and their impact on antibiotic prescribing, referral to hospital and on patient outcome, be assessed. 31 Combinations of symptoms and signs in accident and emergency settings provide additional diagnostic value, prior to radiological or haematological investigation. 2 Future studies in community settings should adopt the same approach.
Conclusions
This systematic review of diagnostic accuracy studies suggest that the value of CRP (cut-point < 20 mg/l) may be of value in ruling out a diagnosis of CAP in situations where the probability of CAP is higher than 10%, typically accident and emergency departments. In primary care settings where the probability of CAP appears to be between 5% and 10%, additional diagnostic testing with CRP is unlikely to alter the probability of CAP sufficiently to change subsequent management decisions such as antibiotic prescribing or referral to hospital. The diagnostic value of CRP to rule in a diagnosis of CAP requires further study. Family Practice-an international journal 
